Jennifer Lynn
Founder and CEO, Ashlins Pharmaceuticals · 1 appearance on the record.
computed by AI from the episodes · how this works → · full disclaimer →
founderexecutiveashlinspharma.com ↗
Jennifer Lin is a Thiel Fellow and biotechnology entrepreneur dedicated to developing and repurposing therapies for rare diseases. After establishing AUG Therapeutics to advance late-stage candidates for leukocyte adhesion deficiency type II, she founded Ashlins Pharmaceuticals to in-license clinically validated assets for formal FDA approval.
1 supported 0 partly supported 0 contradicted how the 1 claim stands · each chip opens the sources
1 assertion · 1 insight · every statement was checked. The predictions and assertion are the 1 claim: statements the public record can support or contradict. 1 is resolved. Everything else (opinions, insights, what ifs, disclosures) can never be settled by the record, so it carries no assessment.
The record, in short
What the tape says about how Jennifer argues and how the claims held up. Everything they said, and everything said about them, is in the tabs below.
Their most notable supported claim
How they sound: not measured why? →
We measure speaking style by listening to the audio itself, and a fair number needs at least 2,000 words from one person on tape we have measured. There is too little of Jennifer Lynn on measured tape to publish a rate. This says nothing about how they speak.
Everything Jennifer Lynn said on TBPN that made the record, most notable first. Filter by type, assessment or year in the ledger →
Appearances (1)
| Episode | Date | Speaking time |
|---|---|---|
| We Interviewed the New Thiel Fellow Dropouts | May 28, 2025 | 5m |